MicroRNAs in cancer. From bench to bedside

Maria Angelica Cortez, Cristina Ivan, Peng Zhou, Xue Wu, Mircea Ivan, George Adrian Calin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

microRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these noncoding RNAs can regulate the expression of more than half of all protein-coding genes in mammalian genomes. Aberrant miRNA expression is well characterized in cancer progression and has prognostic implications for cancer in general. Over the past several years, accumulating evidence has demonstrated that genomic alterations in miRNA genes are correlated with all aspects of cancer biology. In this review, we describe the effects of miRNA deregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells as well as in cancer diagnosis and therapy in humans.

Original languageEnglish
Pages (from-to)113-157
Number of pages45
JournalAdvances in Cancer Research
Volume108
Issue numberC
DOIs
StatePublished - 2010

Fingerprint

MicroRNAs
Neoplasms
Untranslated RNA
Regulator Genes
Genome
Gene Expression
Messenger RNA
Genes
Proteins
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Angelica Cortez, M., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Adrian Calin, G. (2010). MicroRNAs in cancer. From bench to bedside. Advances in Cancer Research, 108(C), 113-157. https://doi.org/10.1016/B978-0-12-380888-2.00004-2

MicroRNAs in cancer. From bench to bedside. / Angelica Cortez, Maria; Ivan, Cristina; Zhou, Peng; Wu, Xue; Ivan, Mircea; Adrian Calin, George.

In: Advances in Cancer Research, Vol. 108, No. C, 2010, p. 113-157.

Research output: Contribution to journalArticle

Angelica Cortez, M, Ivan, C, Zhou, P, Wu, X, Ivan, M & Adrian Calin, G 2010, 'MicroRNAs in cancer. From bench to bedside', Advances in Cancer Research, vol. 108, no. C, pp. 113-157. https://doi.org/10.1016/B978-0-12-380888-2.00004-2
Angelica Cortez, Maria ; Ivan, Cristina ; Zhou, Peng ; Wu, Xue ; Ivan, Mircea ; Adrian Calin, George. / MicroRNAs in cancer. From bench to bedside. In: Advances in Cancer Research. 2010 ; Vol. 108, No. C. pp. 113-157.
@article{6a352eab2cef407d99eef4d54a79545d,
title = "MicroRNAs in cancer. From bench to bedside",
abstract = "microRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these noncoding RNAs can regulate the expression of more than half of all protein-coding genes in mammalian genomes. Aberrant miRNA expression is well characterized in cancer progression and has prognostic implications for cancer in general. Over the past several years, accumulating evidence has demonstrated that genomic alterations in miRNA genes are correlated with all aspects of cancer biology. In this review, we describe the effects of miRNA deregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells as well as in cancer diagnosis and therapy in humans.",
author = "{Angelica Cortez}, Maria and Cristina Ivan and Peng Zhou and Xue Wu and Mircea Ivan and {Adrian Calin}, George",
year = "2010",
doi = "10.1016/B978-0-12-380888-2.00004-2",
language = "English",
volume = "108",
pages = "113--157",
journal = "Advances in Cancer Research",
issn = "0065-230X",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - MicroRNAs in cancer. From bench to bedside

AU - Angelica Cortez, Maria

AU - Ivan, Cristina

AU - Zhou, Peng

AU - Wu, Xue

AU - Ivan, Mircea

AU - Adrian Calin, George

PY - 2010

Y1 - 2010

N2 - microRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these noncoding RNAs can regulate the expression of more than half of all protein-coding genes in mammalian genomes. Aberrant miRNA expression is well characterized in cancer progression and has prognostic implications for cancer in general. Over the past several years, accumulating evidence has demonstrated that genomic alterations in miRNA genes are correlated with all aspects of cancer biology. In this review, we describe the effects of miRNA deregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells as well as in cancer diagnosis and therapy in humans.

AB - microRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these noncoding RNAs can regulate the expression of more than half of all protein-coding genes in mammalian genomes. Aberrant miRNA expression is well characterized in cancer progression and has prognostic implications for cancer in general. Over the past several years, accumulating evidence has demonstrated that genomic alterations in miRNA genes are correlated with all aspects of cancer biology. In this review, we describe the effects of miRNA deregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells as well as in cancer diagnosis and therapy in humans.

UR - http://www.scopus.com/inward/record.url?scp=77958449792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958449792&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-380888-2.00004-2

DO - 10.1016/B978-0-12-380888-2.00004-2

M3 - Article

C2 - 21034967

AN - SCOPUS:77958449792

VL - 108

SP - 113

EP - 157

JO - Advances in Cancer Research

JF - Advances in Cancer Research

SN - 0065-230X

IS - C

ER -